• Saffelberg Investments

Liège, 30 March 2012 - Uteron Pharma successfully completed a 14 million EUR capital increase. This new equity round enables Uteron Pharma to further finance its strong growth ambitions as a specialist in female healthcare.


Press Release

© 2020 created by Saffelberg Investments. All rights reserved.